Nuveen, LLC Inmune Bio, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 16,518 shares of INMB stock, worth $120,581. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,518Holding current value
$120,581% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INMB
# of Institutions
84Shares Held
7.1MCall Options Held
270KPut Options Held
42.9K-
Vanguard Group Inc Valley Forge, PA827KShares$6.03 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$5.93 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR812KShares$5.93 Million1.52% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$4.35 Million45.87% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL476KShares$3.47 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $131M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...